NO! R M N O - TheStreet
Sell NOW! ? 50 Sell-Rated Stocks You Must Not Own
2
With the Dow Jones Industrial Average testing the 29,000 level, are you wondering why some of the stocks in your portfolio have not joined the profit party? This is not the time to double-down on losers hoping beyond rationality that the stock can spring back to life.
Check out TheStreet Quant Ratings' list of fifty worst sell-rated stocks you must not own to see if any of these pests are infecting your portfolio. Consider dumping them in order to seek greener pastures.
These stocks all trade at a recent closing price of at least $10 a share and have average daily volumes above 100,000. Their `Sell' recommendations, based on ratings from TheStreet Ratings' unbiased stock model, show the worst possible combinations of performance potential and risk. `Sell' rated stocks range from grades of D+ down to E-, or even F if bankrupt.
When trading individual stocks, especially low-rated stocks, you can lose money. However, utilizing TheStreet Quant Ratings to screen your investment candidates is a good way to begin your due diligence. As our ratings are subject to change, please check our stock ratings screener for the latest updates.
Company FIRSTENERGY CORP PG&E CORP HOSTESS BRANDS INC CURO GROUP HLDGS CORP UNISYS CORP TILRAY INC ROSETTA STONE INC RADIUS HEALTH INC BENEFITFOCUS INC PORTOLA PHARMACEUTICALS INC PLURALSIGHT INC OMEROS CORP TG THERAPEUTICS INC WAYFAIR INC PUXIN LTD -ADS DERMIRA INC
Ticker FE PCG
TWNK CURO
UIS TLRY RST RDUS BNFT PTLA PS OMER TGTX
W NEW DERM
Overall Grade F F F E+ E+ DDDDDDDDDDD-
Reward Grade F F F C+ ED EE+ E+ E+ D+ E+ E+ E+ DE+
Risk Grade F F F E+ D E+ E+ E+ E+ DE+ E+ E+ E+ DD-
Redistribution is prohibited without the express written consent of TheStreet, Inc. ? 2020 TheStreet, Inc., 14 Wall Street, 15th Floor, New York, NY 10005. All rights reserved. Last updated: 1/15/2020
Sell NOW! ? 50 Sell-Rated Stocks You Must Not Own
3
Company CADIZ INC FLEXION THERAPEUTICS INC LTD ARAVIVE INC AERIE PHARMACEUTICALS INC INTERCEPT PHARMA INC NANOSTRING TECHNOLOGIES INC UNIQURE NV IQIYI INC -ADR PLAYAGS INC ULTRAGENYX PHARMACEUTICAL CARA THERAPEUTICS INC AGIOS PHARMACEUTICALS ACCELERATE DIAGNOSTICS INC DIGIMARC CORP CYTOKINETICS INC SAGE THERAPEUTICS INC NEWMARK GROUP INC FOCUS FINANCL PRTNR LLC FARFETCH LTD TPG RE FINANCE TRT INC MACROGENICS INC INSMED INC KARYOPHARM THERAPEUTICS INC THERAVANCE BIOPHARMA INC ASSEMBLY BIOSCIENCES INC NUTANIX INC AVAYA HLDGS CORP ELASTIC NV GRANITE POINT MORTGE TRS INC RECRO PHARMA INC ARQULE INC CUSHMAN & WAKEFIELD CONSOL ENERGY INC
Ticker CDZI FLXN WIX ARAV AERI ICPT NSTG QURE IQ AGS RARE CARA AGIO AXDX DMRC CYTK SAGE NMRK FOCS FTCH TRTX MGNX INSM KPTI TBPH ASMB NTNX AVYA ESTC GPMT REPH ARQL CWK CEIX
Overall Grade DDDDDDDDDD D D D D D D D D D D D D D D D D D D D D D D D D
Reward Grade DE+ EE+ E+ E+ DE+ D D+ DDDDDE+ E+ B+ B D ADDE+ E+ E+ E+ D+ D B+ E+ E+ C+ C
Risk Grade E+ E+ DD DDDDDDD D DE+ DE+ DD+ DDDD DDE+ D E+ DE+ DD DDD-
Redistribution is prohibited without the express written consent of TheStreet, Inc. ? 2020 TheStreet, Inc., 14 Wall Street, 15th Floor, New York, NY 10005. All rights reserved. Last updated: 1/15/2020
Want to supercharge what you discovered in Quant Ratings for even more profit potential?
You Want
TRIFECTA STOCKS!
Trifecta Stocks are the top 1% of all stocks available on the US stock exchanges.
They are the perfect stocks to start a new portfolio with, upgrade an existing portfolio, or become your ONLY portfolio.
They are the needle in the haystack...the four leaf clover in a vast meadow...the 10-carat diamond in a ton of dirt.
Trifecta Stocks Pass THREE Layers of Intense Scrutiny:
? Ranked a "Buy" in Quant Ratings, TheStreet's Award-Winning Stock Rating Service
? Judged Superior by TheStreet's Top Fundamental Researcher
? Earn a "Buy Signal" from TheStreet's Top Technical Expert
If you want the BEST, you need to own Trifecta Stocks.
Just accept our invitation to start a 14-Day FREE trial to Trifecta Stocks today and get the the names of every single one of these special companies.
READ ON TO FIND OUT MORE!
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.